NCT00708045 2024-03-15
Chemobrain
University of Utah
Phase 1 Completed
Clinical Trials
11 trialsNCT03493789 2023-10-18
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Emory University
Phase 1 Completed
NCT00813566 2022-04-27
Multi-Tracer PET Assessment of Primary Brain Tumors
University of Utah
Phase 1 Completed
NCT01537107 2019-04-08
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Mayo Clinic
Phase 1 Completed
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT01561014 2018-07-02
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Wake Forest University Health Sciences
Phase 1 Completed
NCT00019565 2016-09-26
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00039286 2015-12-24
Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00109785 2015-12-24
PET Scans in Patients With Locally Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00864110 2013-03-22
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Cell>Point LLC
Phase 1 Completed
NCT01017133 2012-09-26
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed